The data presented above demonstrated that BST-2-induced HBV restriction in hepatoma and hepatic cells is weaker than that in 293T cells, indicating that HBV may counteract BST-2 in hepatocytes. The gene discussed is BST2; the disease is hepatocellular carcinoma.